Emma Andrus, Editor

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Lars French, MD, explains how the new WHA resolution on skin health could drive training, access, and global policy change.

A new WHA resolution spotlights skin health, pushing member states to close care gaps and integrate dermatology into public health.

Topical ruxolitinib, phototherapy, and psychosocial care took center stage in an interactive discussion between Seemal Desai, MD, FAAD, and colleagues, on managing complex vitiligo cases.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Johnson & Johnson submitted an NDA for icotrokinra, a promising new treatment for moderate to severe plaque psoriasis in adults and adolescents.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Rigorous pre-, intra-, and postoperative protocols help ensure safe, effective periocular laser treatments and reduce the risk of ocular complications.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

A systematic review reveals significant Treg cell deficiencies in vitiligo, highlighting their role as therapeutic targets for improved treatment strategies.

This review of the latest dermatologic studies includes insights into ocular safety during laser procedures, radiation dermatitis prevention and management, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Renata Block, DMSc, MMS, PA-C, interviews Amy Snow, PA-C, who shares how she transformed career roadblocks into a mobile dermatology clinic delivering free care and hope across Oregon.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Sun Pharmaceuticals has launched deuruxolitinib (Leqselvi) in the US, offering a new treatment for adults with severe alopecia areata.

The pharmaceutical companies announced an exclusive global license and transfer agreement for the advancement and commercialization of Spevigo.

Melanoma survivors share their diagnoses and advocate for early detection, routine skin exams, and public education to save lives.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about APG777 EASI-75 response rates in atopic dermatitis, the unblinding of VYN202 after a safety pause, spesolimab and skin clarity between flares, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Ethanol-based hand sanitizer showed no visible skin toxicity in rats, but subclinical dermatitis raised concerns about dermal test guideline adequacy.

After 4 months of treatment with the dual therapy, patients with refractory vitiligo exhibited an overall 55% remission rate.

Exclusive Report: A comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first half of 2025.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Zelsuvmi is the first FDA-approved at-home treatment for molluscum contagiosum, now available for patients aged ≥1 via retail and mail-order pharmacies.

Catch up on dermatology news, highlights, and insights from the past 24 hours.